Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Duopharma Oy
OY
Dissolved
Y-tunnus 2279771-9
Juhonkuja 10B, 33300
Tampere
Retail sale of medical and orthopaedic goods
·
NACE 4774
Est. 2009 · 16 years old
— employees
Share
Finland
/
Companies
/
Retail sale of medical and orthopaedic goods
/
Duopharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2019
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2019
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
EUR thousands
Item
2019
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
−0
−0
EBITDA
1
20
0
0
0
Depreciation & amort.
—
—
—
−0
−0
EBIT
1
20
0
0
0
Net financials
—
—
−2
−2
0
Profit before tax
1
20
−2
−2
0
Tax
−0
−0
−0
−0
−0
Net profit
1
20
−2
−2
0
Balance sheet
EUR thousands
Item
2019
2021
2022
2023
2024
Total assets
14
23
22
22
22
Equity
−112
−101
−103
−103
−103
Long-term debt
124
124
124
124
124
Short-term debt
2
0
1
1
1
Total debt
126
124
125
125
125
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2019
2024
Equity ratio
-463.5%
This company
38.2%
Market median
-1313% vs market
2019
2024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2019
2024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2019
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2019
2024
Debt / equity
1.22×
This company
0.62×
Market median
-97% vs market
2019
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2019
Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
View
PDF
More on Duopharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
